229009-41-0 Usage
Uses
Used in Organic Synthesis:
(4-PYRROLIDIN-1-YLPHENYL)BORONIC ACID is used as a reagent in organic synthesis for its ability to facilitate the formation of carbon-carbon and carbon-nitrogen bonds, which is crucial for the creation of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (4-PYRROLIDIN-1-YLPHENYL)BORONIC ACID is used as a key intermediate in the development of new drugs, particularly targeting areas such as cancer and diabetes research. Its structural properties allow for the design of novel therapeutic agents that can potentially address unmet medical needs.
Used in Antimicrobial Applications:
(4-PYRROLIDIN-1-YLPHENYL)BORONIC ACID is used as an antimicrobial agent due to its potential to inhibit the growth of various microorganisms, offering a new avenue for the development of antimicrobial drugs.
Used in Anti-inflammatory Applications:
In the field of inflammation and related conditions, (4-PYRROLIDIN-1-YLPHENYL)BORONIC ACID is used as an anti-inflammatory agent, leveraging its properties to potentially reduce inflammation and associated symptoms.
Overall, (4-PYRROLIDIN-1-YLPHENYL)BORONIC ACID's diverse applications in chemical synthesis, pharmaceutical development, and medical research highlight its importance as a versatile and promising compound in scientific exploration.
Check Digit Verification of cas no
The CAS Registry Mumber 229009-41-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,9,0,0 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 229009-41:
(8*2)+(7*2)+(6*9)+(5*0)+(4*0)+(3*9)+(2*4)+(1*1)=120
120 % 10 = 0
So 229009-41-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H14BNO2.ClH/c13-11(14)9-3-5-10(6-4-9)12-7-1-2-8-12;/h3-6,13-14H,1-2,7-8H2;1H
229009-41-0Relevant academic research and scientific papers
NOVEL LIGANDS THAT MODULATE RAR RECEPTORS, AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS
-
Page/Page column 46, (2008/06/13)
The present invention relates to novel compounds corresponding to the general formula (I) below: to compositions containing them, to processes for preparing them and to their use in pharmaceutical compositions intended for use in human or veterinary medic